Landscapes / Companies
Humacyte, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 5 in all
Trials
4 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Jun 2027Phase 3 trial completes | |||
| Next date | Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Arterial Injury, End Stage Renal Disease (ESRD) and 4 more | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2030Phase 2 trial completes | |||
| Next date | Sep 2030 · Phase 2 trial completes | ||||
| Also tested for | Coronary Artery Disease | ||||
| Open drug page | |||||
About
- No active trial
- HAV, HAVG, Human Acellular Vessel
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021